Number of Credits
Whether you are a Laboratory Director or simply want to learn more about the responsibilities and duties of directing a laboratory, this recorded webinar, presented by an experienced laboratory director, will provide a clear perspective into the position.
This Webinar CEexpress course focuses on:
• Summarizing the CLIA qualification requirements to be a laboratory director of a moderate complexity and/or high complexity physician office laboratory
• Meeting the responsibilities (according to CLIA) of the laboratory director
• Evaluating which duties may be delegated to other laboratory personnel
The course links you to an archived version of the webinar slide and audio program, and to available pdf file resources. Your computer must have audio capabilities to hear the audio portion of the presentation.
This course has been approved for CME credit. You must successfully complete the quiz and submit the course evaluation to receive credit.
Verlin Janzen, MD, FAAFP is a family physician practicing at the Hutchinson Clinic in Hutchinson, Kansas. He also serves as director of the clinic’s laboratory, serving 50+ physicians, outreach clinics and local nursing homes. Dr. Janzen’s undergraduate training and Bachelor’s degree were in medical technology. He worked as a Medical Technologist for 3½ years while studying for a Master’s degree in laboratory management and administration. He attended medical school at the University of Nebraska and completed his residency in Family Medicine at St. Joseph’s Hospital, Wichita, KS.
Physician office laboratory issues have been a natural for Dr. Janzen with his training covering both laboratory and clinical medicine. He has served on a variety of committees dealing with POL issues including the CAP Primary Care Lab Practice Committee, the AAFP Proficiency Testing Committee, the AAFP Health Care Services Subcommittee on Laboratory Issues, the NCCLS Subcommittee on User Demonstration of Performance, and the Clinical Laboratory Improvement Advisory Committee (CLIAC) at the CDC. He is the Chair of the Accreditation Committee of the COLA Board of Directors, and the Past-President of the Kansas Academy of Family Physicians. Dr. Janzen has given talks around the country to various organizations and groups on POL issues and he presents the Lab Director Qualification sessions at the Symposium for Clinical Laboratories.
This CME activity has been designed to change learner competence and focuses on the American Board of Medical Specialties areas of patient care, practice-based learning and systems-based practice.
This Enduring Material activity, Laboratory Director Continuing Education Program, has been reviewed and is acceptable for credit by the American Academy of Family Physicians. Term of approval begins 08/01/2019. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Approved for 1.0 AAFP Prescribed credits.
AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 Credit™ toward the AMA Physician’s Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.
This course will take 1 hour to complete and there are no prerequisites. A credit certificate will be issued upon completion of the course evaluation and post-test with a score of 80% or better.
Release Date: 8/1/2017
Expiration Date: 8/1/2018
Free, current version of Internet Explorer, Chrome, Firefox, or Safari. (Some older browsers could produce error messages or not display the content correctly.)
Free, current version of Adobe Flash Player and Adobe Reader.
It is the policy of the AAFP and COLA Resources, Inc. that the faculty, authors, planners, and other persons who may influence content of this CME activity disclose all relevant financial relationships with commercial interests* in order to allow CME staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). For this educational activity all conflicts of interests have been resolved and detailed disclosures are listed below:
Author: and Activity Planner: Verlin K. Janzen, MD, FAAFP
No relevant financial relationships to disclose, No discussion of unlabeled/unapproved uses of drugs/devices during presentation.
* The ACCME defines a commercial interest as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients The ACCME does not consider providers of clinical service directly to patients to be commercial interests.